Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ivan Batlle (NPI 1073510962)

Field	Value
Entity Type	Individual
Organization	Ivan Batlle
Address	8600 Quivira Rd Ste 100
City	Lenexa
State	KS
ZIP	66215
Taxonomy	Ophthalmology Physician
NPI Enumerated	July 7, 2005

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

Provider tenure and specialty: NPI enumerated (registered) 2005-07-07 (~21 years ago) and taxonomy listed as Ophthalmology Physician, indicating long-standing individual practice history focused on eye care and retinal procedures. The longevity supports an established referral and follow-up base for ophthalmic services.

Payer mix and scale: This provider is effectively single‑payer in the dataset — Total Medicare revenue is $1.9M while Medicaid billing is recorded as none, so Medicaid does not contribute to the reported revenue mix and the practice appears dependent on Medicare reimbursement.

Revenue concentration: Intravitreal drug administrations dominate Medicare revenue — the precomputed top‑3 Medicare codes account for 69.9% of total Medicare revenue, driven primarily by J0178 (aflibercept) which alone represents $948.1K or 50.6% of Medicare revenue. That concentration signals a high reliance on injectable biologics for the practice’s billing profile.

Service-line implications: The code mix (J0178, J2777, J2778, plus imaging codes 92134 and 92250 and surgery codes such as 67108 and 67041) indicates a retina‑focused ophthalmology practice that combines high-volume intravitreal pharmacotherapy with diagnostic retinal imaging and occasional surgical retina procedures. High counts for imaging (92134: 1.9K claims) and fundus photography (92250: 841 claims) support an office workflow centered on retinal disease management and monitoring.

Competitive standing on major drug codes: For the largest revenue driver, J0178 the provider ranks #917 of 3204 nationally (71th percentile; typical, unremarkable volume for this code), indicating meaningful but not market-dominant participation in aflibercept administration. J2777 and J2778 rank at 43th and 53th percentiles respectively, so faricimab and ranibizumab use are present but not unusually concentrated relative to peers.

High office‑visit and diagnostic volume relative to peers: E/M and imaging codes are statistical outliers nationally — 99214 shows $103.3K revenue and ranks #5999 of 479517 (99th percentile; extreme outlier, far above typical national volume for this code), and 92250 shows $21K revenue and ranks in the 98th percentile (extreme outlier). These extreme percentile positions for evaluation/management and fundus photography imply unusually high office throughput and diagnostic imaging intensity compared with national peers.

Notable mid‑tier drug and device activity: The provider reports meaningful revenue from J2777 ($236.6K, 12.6%) and J2778 ($124.2K, 6.6%), plus smaller but material contributions from J7312 ($53.4K, 2.9%) and J3490 ($52.3K, 2.8%). Ranks for these codes are mixed (for example J7312 is at the 73th percentile while J3490 is at the 19th percentile), suggesting selective use of implants and occasional unclassified drug billing rather than broad national leadership in these niches.

Access and strategic implications of no Medicaid billing: With no Medicaid billing on file, the practice’s patient access and revenue exposure are concentrated in the Medicare population; payers and network analysts should treat this provider as a Medicare-focused retina practice when modeling network capacity, utilization, or negotiating arrangements.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,370	$690	$948.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	8,160	$30	$236.6K
J2778	Injection, ranibizumab, 0.1 mg	700	$180	$124.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,250	$90	$108.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,280	$80	$103.3K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	340	$160	$53.4K
J3490	Unclassified drugs	30	$1,800	$52.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,920	$30	$51.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	270	$110	$29.6K
J3590	Unclassified biologics	400	$70	$29K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Ivan Batlle — 4 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	16	30	1,770	$690	$1.3M
J2777	20	30	12,060	$30	$575.7K
J2778	15	20	860	$180	$297.6K
67028	17	40	1,170	$90	$111.4K
J2781	2	10	230	$120	$69.3K
J7312	3	10	260	$160	$43.6K
67042	17	20	20	$1,140	$31.9K
67108	4	20	20	$1,130	$24.8K
J3590	3	20	200	$100	$24.1K
J3490	19	20	120	$200	$23.4K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ivan Batlle, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Ivan Batlle, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bethesda Lutheran Communities	KS	Mental Illness Intermediate Care Facility	$0	$17.6M
Cherub Medical Supply, LLC	KS	Durable Medical Equipment & Medical Supplies	$0	$6.3M
Mawd Pathology Group Inc	KS	Anatomic Pathology & Clinical Pathology Physician	$660	$5.9M
Gregory Fox	KS	Ophthalmology Physician	$4M	$0
Ravi Singh	KS	Ophthalmology Physician	$3.9M	$0
Cpf Senior Living - Lenexa LLC	KS	Assisted Living Facility	$0	$3.8M
Beatty Suiter	KS	Ophthalmology Physician	$3.5M	$0
Ryan Christensen	KS	Ophthalmology Physician	$3.3M	$0
180 Medical, Inc.	KS	Durable Medical Equipment & Medical Supplies	$0	$2.7M
Midwest Division-oprmc LLC	KS	General Acute Care Hospital	$0	$2.6M

Ivan Batlle — Billing Profile & Reimbursement Data

Sign up for Ivan Batlle — Billing Profile & Reimbursement Data policy alerts

Ivan Batlle — Billing Profile & Reimbursement Data

Sign up for Ivan Batlle — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References